An open randomised controlled clinical study on efficacy of Loha Amrutama(Rasa ratnakar) and Navayasa Churna(Charak) in Pandu roga with special reference to Iron deficiency anaemia.
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- To check the improvement in the symptoms mentioned in the subjective and objective criteria on respective follow ups.
研究概览
简要总结
Iron deficiency anaemia is most common nutrition deficiency disorder worldwide. According to National family health survey data the incidence of anaemia is 79 % the national family health survey data suggests that the prevalence of anaemia in adolscent is 56%. In Ayurveda iron deficiency anaemia can correlate with Pandu roga. Ayurveda combinations indicated for Pandu comprise of other Drugs along with Loha/ Mandur bhasma.
So, beauty of Ayurveda preparation lies in assuring digestion, metabolism and excretion (after complete utilisation) of the doing without any untoward reactions and side effects.
In this trial, I have selected two drugs for my clinical trial with almost equal quantity of Loha bhasma(to avoid bias) .In due course of trial, I shall study mode of action, indication of the drug and efficacy as well.
研究设计
- 研究类型
- Interventional
- 分配方式
- Random Number Table
- 盲法
- Open Label
入排标准
- 年龄范围
- 16.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Patient having Prayatma lakshanas of pandu roga Pandutha Arohan Ayasa Pindikodweshtana Klama Hb Percentage between 7-12g% male & 7-10g% in females.
排除标准
- •Pregnant women & lactating mothers.
- •Patients suffering from infectious diseases.
- •Patients who has acute or chronic blood loss.
- •Patients with systemic disorders that would interfere with course of the study.
- •All types of secondary, congenital and hereditary anaemia.
- •Patients who do not give consent for treatment.
结局指标
主要结局
To check the improvement in the symptoms mentioned in the subjective and objective criteria on respective follow ups.
时间窗: 10th day,20th day,30th day
次要结局
- To find out the adverse effect of Loha amrutama on respective follow ups.(1Oth day,20th day,30th day)